Artivion

AORT

Insider trades and stock quote 2024-2026

All insider trades at Artivion

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/12/2026 Sell Holloway, Jean F. SVP, General Counsel $28.5 $27,835
6/11/2026 Sell Green, Andrew M. SVP, Regulatory and Quality $20.7 $910,739
3/4/2026 Sell Holloway, Jean F. SVP, General Counsel $38.0 $340,556
3/3/2026 Sell Mackin, James P. President & CEO $37.8 $675,692
3/3/2026 Sell Berry, Lance A. EVP, COO, CFO & Treasurer $37.8 $238,591
3/3/2026 Sell Davis, John E. Chief Commercial Officer $37.8 $172,748
3/3/2026 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $37.8 $81,180
3/3/2026 Sell Holloway, Jean F. SVP, General Counsel $37.8 $145,172
3/3/2026 Sell Horton, Amy VP, Chief Accounting Officer $37.8 $34,036
3/2/2026 Sell Davis, John E. Chief Commercial Officer $38.0 $105,861
3/2/2026 Sell Berry, Lance A. EVP, COO, CFO & Treasurer $38.0 $196,893
3/2/2026 Sell Holloway, Jean F. SVP, General Counsel $38.0 $83,008
3/2/2026 Sell Mackin, James P. President & CEO $38.0 $566,989
3/2/2026 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $38.0 $57,532
3/2/2026 Sell Horton, Amy VP, Chief Accounting Officer $38.0 $24,374
2/24/2026 Sell Davis, John E. Chief Commercial Officer $35.7 $74,063
2/24/2026 Sell Berry, Lance A. EVP, COO, CFO & Treasurer $35.7 $160,083
2/24/2026 Sell Mackin, James P. President & CEO $35.7 $497,418
2/24/2026 Sell Holloway, Jean F. SVP, General Counsel $35.7 $59,536
2/24/2026 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $35.7 $44,937
2/24/2026 Sell Horton, Amy VP, Chief Accounting Officer $35.7 $29,625
2/23/2026 Sell Davis, John E. Chief Commercial Officer $37.6 $141,820
2/23/2026 Sell Berry, Lance A. EVP, COO, CFO & Treasurer $37.6 $187,226
2/23/2026 Sell Mackin, James P. President & CEO $37.6 $787,920
2/23/2026 Sell Holloway, Jean F. SVP, General Counsel $37.6 $115,733
2/23/2026 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $37.6 $91,076
2/23/2026 Sell Horton, Amy VP, Chief Accounting Officer $37.6 $65,065
12/15/2025 Sell Davis, John E. Chief Commercial Officer $45.1 $225,550
12/8/2025 Sell Horton, Amy VP, Chief Accounting Officer $44.4 $203,084
12/3/2025 Sell Holloway, Jean F. SVP, General Counsel $45.3 $331,369
12/3/2025 Sell Mackin, James P. President & CEO $45.5 $1,405,700
12/2/2025 Sell Mackin, James P. President & CEO $45.6 $1,408,730
11/21/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $45.1 $2,133,921
11/20/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $44.2 $674,825
11/18/2025 Sell Hoff, Elizabeth A. Director $45.1 $189,412
11/17/2025 Sell Horton, Amy VP, Chief Accounting Officer $45.7 $274,380
11/17/2025 Sell Davis, John E. Chief Commercial Officer $45.2 $288,817
11/17/2025 Sell Holloway, Jean F. SVP, General Counsel $45.2 $288,817
11/14/2025 Sell Davis, John E. Chief Commercial Officer $44.7 $285,575
11/14/2025 Sell Holloway, Jean F. SVP, General Counsel $45.0 $287,685
11/13/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $45.9 $228,969
11/13/2025 Sell Holloway, Jean F. SVP, General Counsel $45.9 $264,188
11/13/2025 Sell Mackin, James P. President & CEO $45.9 $1,568,802
11/13/2025 Sell Davis, John E. Chief Commercial Officer $45.9 $300,966
11/13/2025 Sell Horton, Amy VP, Chief Accounting Officer $45.9 $159,678
11/11/2025 Sell Holloway, Jean F. SVP, General Counsel $46.2 $461,800
11/10/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $44.6 $114,492
11/10/2025 Sell Horton, Amy VP, Chief Accounting Officer $44.6 $79,823
11/10/2025 Sell Davis, John E. Chief Commercial Officer $44.6 $150,500
11/10/2025 Sell Mackin, James P. President & CEO $44.6 $784,402
11/10/2025 Sell Holloway, Jean F. SVP, General Counsel $44.6 $132,072
8/27/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $44.0 $801,219
8/25/2025 Sell Holloway, Jean F. SVP, General Counsel $44.4 $443,700
8/15/2025 Sell Mackin, James P. President & CEO $42.3 $528,988
8/12/2025 Sell Holloway, Jean F. SVP, General Counsel $43.0 $1,004,610
8/12/2025 Sell Davis, John E. Chief Commercial Officer $43.7 $471,756
8/8/2025 Sell Horton, Amy VP, Chief Accounting Officer $38.5 $307,612
6/17/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $29.5 $442,500
6/13/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $28.4 $743,132
5/27/2025 Sell Holloway, Jean F. SVP, General Counsel $29.0 $253,692
5/23/2025 Sell Semedo, Anthony B. Director $28.5 $148,054
5/21/2025 Sell Holloway, Jean F. SVP, General Counsel $29.0 $287,854
5/9/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $29.1 $307,265
3/11/2025 Sell Davis, John E. Chief Commercial Officer $23.6 $356,549
3/11/2025 Sell Holloway, Jean F. SVP, General Counsel $23.6 $425,510
3/6/2025 Sell Holloway, Jean F. SVP, General Counsel $24.8 $52,685
3/6/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $24.8 $39,761
3/6/2025 Sell Davis, John E. Chief Commercial Officer $24.8 $64,939
3/6/2025 Sell Berry, Lance A. Executive VP, CFO $24.8 $121,764
3/6/2025 Sell Horton, Amy VP, Chief Accounting Officer $24.8 $25,995
3/6/2025 Sell Mackin, James P. President & CEO $24.8 $2,190,848
3/5/2025 Buy Semedo, Anthony B. Director $25.3 $53,141
3/5/2025 Sell Holloway, Jean F. SVP, General Counsel $25.3 $11,935
2/24/2025 Sell Stanton, Marshall S. SVP, Clinical & MD Affair $27.3 $127,983
2/24/2025 Sell Berry, Lance A. Executive VP, CFO $27.3 $88,990
2/24/2025 Sell Davis, John E. Chief Commercial Officer $27.3 $176,315
2/24/2025 Sell Holloway, Jean F. SVP, General Counsel $27.3 $145,678
2/24/2025 Sell Mackin, James P. President & CEO $27.3 $1,151,111
2/24/2025 Sell Horton, Amy VP, Chief Accounting Officer $27.3 $90,737
12/11/2024 Sell Holloway, Jean F. SVP, General Counsel $30.1 $243,109
12/6/2024 Sell Horton, Amy VP, Chief Accounting Officer $29.4 $256,950
12/4/2024 Sell Green, Andrew M. VP Regulatory $30.0 $228,540
10/1/2024 Sell Horton, Amy VP, Chief Accounting Officer $26.2 $325,415
8/26/2024 Sell Holloway, Jean F. SVP, General Counsel $26.6 $84,096
8/16/2024 Sell Getz, Matthew A. VP, Human Resources $25.3 $238,434
8/15/2024 Sell Holloway, Jean F. SVP, General Counsel $25.8 $61,393
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)